Just another WordPress site

Greater delay discounting and cannabis coping motives are associated with more frequent cannabis use in a large sample of adult cannabis users

Sep 27, 2022



Self-regulation deficits expressed through a decreased ability to value future rewards (delay discounting (DD)) and impaired emotion regulation (negative urgency (NU), cannabis coping motives (CCM), and anxiety sensitivity (AS)) relate to more frequent or problematic cannabis use. However, there is a need to better understand how self-regulation and emotion regulation constructs reflect competition between deliberative and reactive systems that drive individual differences in cannabis use patterns. Further, few studies assess frequency of cannabis use within and across days of use, which may obscure differentiation of individual differences.


In a large national sample of 2545 cannabis users, Latent Class Analysis was used to derive participant sub-classes based on two frequency indices, self-reported cannabis use days and times cannabis was used per day. Three classes emerged: Low (1–9 days/month, 1 time/day; 23 %), moderate (10–29 days/month, 2–3 times/day; 41 %), and high (30 days/month, ≥4 times/day; 36 %). Relationships among frequency classes and emotional regulation and impulsivity were assessed with a multinomial logistic regression.


Higher frequency use was associated with greater DD (χ2 = 6.0, p = .05), greater CCM (χ2 = 73.3, p < .001), and lower cognitive AS (χ2 = 12.1, p = .002), when controlling for demographics, tobacco use, and number of cannabis administration methods. Frequency class and NU were not significantly associated.


Identifying meaningful patterns of cannabis use may improve our understanding of individual differences that increase risk of frequent or problematic cannabis use. Excessive delay discounting and using cannabis to cope with negative affect may be relevant targets for treatments designed to reduce cannabis use.



Other Posts

Recommended Approaches to Evaluate Methodologies and Technologies for the Detection of Cannabis-Impaired Driving

In September 2023, New York State Department of Health (DOH) issued a Request for Information (RFI) regarding methodologies and technologies used for the detection and assessment of driving under-the-influence of cannabis (DUIC). The RFI purpose is to assist the DOH in assessing the current state of research on impairment due to cannabis ingestion, and to review current devices that can be used to detect impairment. Moreover, the DOH is seeking to identify research institutions in higher education that are currently performing this type of research.

read more

Maryland Medical Cannabis Patient Survey Report 2022

The Maryland Medical Cannabis Commission sponsored this survey and report from Cannabis Public Policy Consulting (CPPC) to examine patterns of use, perceptions of risk and benefit, and occurrence of high-risk
behaviors related to cannabis use in the medical cannabis patient population. More than 13,000 medical cannabis patients took part in the survey, which was conducted in September 2022, prior to the General Election referendum to legalize adult use in the state. A second, post referendum survey is planned for fall 2023.

read more